Davide Leone & Partners Investment Company’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-496,203
Closed -$22.1M 5
2022
Q2
$22.1M Buy
496,203
+385,958
+350% +$19.8M 98.19% 1
2022
Q1
$6.24M Sell
110,245
-965,689
-90% -$50.4M 92.18% 1
2021
Q4
$55.9M Buy
1,075,934
+151,652
+16% +$7.82M 11.18% 2
2021
Q3
$55.2M Buy
924,282
+159,834
+21% +$10.1M 4.23% 5
2021
Q2
$47.5M Hold
764,448
2.27% 6
2021
Q1
$49.8M Buy
764,448
+547,409
+252% +$35.7M 6.21% 7
2020
Q4
$14.3M Buy
+217,039
New +$12.8M 1.49% 16

Other funds holding EHC

Davide Leone & Partners Investment Company's EHC Position: Q3 2022 in Review

Davide Leone & Partners Investment Company sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 496,203 shares — an estimated $22.1M sold.

Davide Leone & Partners Investment Company first reported a position in EHC in Q4 2020 and held it in 7 quarters. The position peaked at $55.9M in Q4 2021. 347 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • Davide Leone & Partners Investment Company reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 496,203 Encompass Health shares in Q3 2022, an estimated $22.1M.
  • Davide Leone & Partners Investment Company first reported a position in Encompass Health in Q4 2020 and held it in 7 quarters.
  • Davide Leone & Partners Investment Company's Encompass Health position peaked at $55.9M in Q4 2021.
  • 347 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2022, filed 14 Nov 2022.